Advancements in the treatment of CLL

In the past years, a great number of new treatments agents have proved effective in the treatment of CLL for different patient groups. New data indicate that not all patient groups benefit in the same manner from immune chemotherapeutic treatments, in this Medtalk Professor Paolo Ghia introduces and provides an overview of the new treatment possibilities, preferred first line treatments and sequence of treatments for different patient groups according to the US and European guidelines.